Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban versus warfarin for left ventricular thrombosis
ChiCTR2100048098Phase 4Not yet recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of rivaroxaban in Left ventricular thrombosis (LVT) (2 arms), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoint: Complete dissolution rate of left ventricular thrombosis at day 90. Planned start Apr 2021; status: not yet recruiting.
02
Drugs
rivaroxaban
03
Conditions
Left ventricular thrombosis (LVT)
Beyond the preview
Go deeper on ChiCTR2100048098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048098.